PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. Q3 FY25 Results
PGHHQ3 FY25 ResultsAnnounced 11 Feb 2025, 03:05 pm| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 1.2K | 9.9% |
| Total Income | 1.3K | 9.9% |
| Expenditure | 893.21 | 4.1% |
| PBT | 364.13 | 27.6% |
| Net Profit | 268.59 | 26.8% |
| OPM | 27.08% | 3.89pp |
| NPM | 21.36% | 2.83pp |
| EPS | 82.74 | 26.8% |
Procter & Gamble Hygiene and Health Care Ltd. Achieves 10% Sales Growth and 17% PAT Increase in Q2 2024
11 Feb 2025 · 11 Feb 2025, 08:41 pm
Summary
Procter & Gamble Hygiene and Health Care Ltd. announced its financial results for the quarter ended December 31, 2024, revealing a 10% increase in sales to 1248 crore and a 17% increase in Profit After Tax (PAT) to 269 crore. The growth was driven by a robust portfolio, consumer-delighting innovation, and superior retail execution. The company also declared an interim dividend of 110 per equity share for the financial year 2024-25.
Key Highlights
- 1
Sales up by 10% to 1248 crore
- 2
Profit After Tax (PAT) increased by 17% to 269 crore
- 3
Growth driven by robust portfolio, innovation, and retail execution
- 4
Interim dividend of 110 per equity share declared for FY 2024-25
Management Comments
Kumar Venkatasubramanian
The Company has delivered a strong double-digit growth across both topline and bottom line in the quarter. This has been led by our continued focus on delighting all consumers with superior propositions and executing the integrated growth strategy- a focused product portfolio of daily use categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and consumer and customer value), productivity, constructive disruption, and an agile and accountable organization.
Informational and educational content only. Not investment advice.